Sector: Health Care
Director information for ORTHOFIX MEDICAL INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| A. BAZAAR | ["Senior Executive Leadership"] | [] | 2026 | ||
| Alan L. Bazaar | Independent Director | 56 | ["Senior Executive Leadership","Mergers & Acquisitions","Corporate Governance, including ESG Matters","Public Company Board","Certified Public Accountant (inactive)"] | ["Audit and Finance Committee","Compensation and Talent Development Committee","Audit & Finance","Compensation & Talent Development"] | 2026 |
| Aviva McPherron | President, Global Operations and Quality | 49 | ["Senior Vice President, Integration and Clinical Services at Globus Medical, Inc.","Chief Transformation Officer, Senior Vice President at NuVasive, Inc.","Chief Information Officer, Vice President of IT at NuVasive, Inc.","Bachelor of Science in Mechanical Engineering from Stanford University"] | ["Board Relations Committee"] | 2026 |
| Charles R. Kummeth | Chair; Independent Director | 65 | ["Senior Executive Leadership","Healthcare Industry","Global Business","Mergers & Acquisitions","Operational Management","Public Company Board"] | ["Compensation and Talent Development Committee","Compensation & Talent Development","Nominating","Governance & Sustainability"] | 2026 |
| C. KUMMETH | ["Operational Management"] | [] | 2026 | ||
| Douglas C. Rice | [] | [] | 2026 | ||
| Jason M. Hannon | Chair; Independent Director | 54 | ["Senior Executive Leadership","Healthcare Industry","Global Business","Mergers & Acquisitions","Corporate Governance, including ESG Matters","Operational Management","Compliance, Quality & Regulatory","Human Resources & Compensation"] | ["Compensation and Talent Development Committee","Compliance & Ethics (Chair)","Compensation & Talent Development","Compliance and Ethics Committee"] | 2026 |
| J. HANNON | ["Mergers & Acquisitions"] | [] | 2026 | ||
| J. HENNEMAN | ["Corporate Governance, including ESG Matters"] | [] | 2026 | ||
| John B. Henneman, III | Chair | 64 | [] | ["Audit and Finance Committee"] | 2026 |
| John Henneman | ["audit committee financial expert"] | ["Audit and Finance Committee"] | 2026 | ||
| John “Jack” B. Henneman, III | 64 | ["Senior Executive Leadership","Former CFO/Financial Expertise","Healthcare Industry","Global Business","Mergers & Acquisitions","Corporate Governance, including ESG Matters","Compliance, Quality & Regulatory","Human Resources & Compensation","Public Company Board","25 years of financial and operational management experience in life sciences","Strategic, marketing, development and transactional advice for startups","Executive Vice President and Chief Financial Officer of NewLink Genetics Corporation","General Counsel and Chief Administrative Officer at Integra LifeSciences Holdings","Board member of various public and private companies"] | ["Nominating, Governance & Sustainability","Audit & Finance"] | 2026 | |
| Kevin J. Kenny | [] | [] | 2026 | ||
| Massimo Calafiore | President and Chief Executive Officer | 54 | ["Led a global orthopedic company focused on digital innovation and customized hardware","Oversaw the company through its acquisition by Enovis Corporation","Managed product marketing, commercial, and commercial enablement functions","Responsible for product and services organization including Spine and Clinical Services","15+ years in leadership roles in orthopedics and medical device industry","Senior Executive Leadership","Health Industry","Global Business","Technology, including Cybersecurity","Mergers & Acquisitions","Compliance, Quality & Regulatory"] | [] | 2026 |
| Max Reinhardt | President, Global Spine | 55 | ["Senior Leadership Roles at Pacira Biosciences, Inc. (2019 – 2024)","Worldwide President at Johnson & Johnson, DePuy Synthes Spine (2015 – 2019)","Vice President, Marketing, U.S. Orthopedics at Johnson & Johnson (2007 – 2010)","Senior Leadership Roles in Europe at Steris Corporation (2001 – 2002)","Senior Leadership Roles in Europe at Olympus KeyMed (1995 – 2001)"] | [] | 2026 |
| M. CALAFIORE | ["Healthcare Industry"] | [] | 2026 | ||
| M. FINEGAN | ["Technology, including Cybersecurity"] | [] | 2026 | ||
| Michael E. Paolucci | Director | 66 | ["Senior Executive Leadership","Healthcare Industry","Global Business","Mergers & Acquisitions","Corporate Governance, including ESG Matters","Human Resources & Compensation","Over 20 years of global experience working with boards of directors and C-level executives"] | ["Audit and Finance Committee","Compensation and Talent Development Committee","Compliance and Ethics Committee"] | 2026 |
| Michael M. Finegan | Chair of the Board | 62 | ["Senior Executive Leadership","Health Industry","Global Business","Mergers & Acquisitions","Operational Management","Compliance, Quality & Regulatory"] | ["Compliance and Ethics Committee","Compliance & Ethics"] | 2026 |
| M. PAOLUCCI | ["Human Resources & Compensation","Public Company Board"] | [] | 2026 | ||
| Patrick Fisher | President, Global Biologics and Limb Reconstruction | 52 | ["Vice President & General Manager at Stryker Corporation","President at Wright Medical Group N.V.","Expertise in global marketing, research and development, sales, and clinical research and medical education"] | [] | 2026 |
| Paul W. Gonsalves | [] | [] | 2026 | ||
| Shweta S. Maniar | Director | 42 | ["Healthcare Industry","Global Business","Technology, including Cybersecurity","Mergers & Acquisitions","Public Company Board"] | ["Audit and Finance Committee","Compensation and Talent Development Committee","Compliance and Ethics Committee","Immunology Scientific Advisory Council of the Allen Institute","Cloud Compliance Advisory Board of USDM Life Sciences"] | 2026 |
| S. MANIAR | ["Compliance, Quality, and Regulatory"] | [] | 2026 | ||
| V. CAPPS | ["Global Business"] | [] | 2026 | ||
| Vickie L. Capps | Director | 64 | ["Senior Executive Leadership","Former CFO/Financial Expertise","Healthcare Industry","Global Business","Mergers & Acquisitions","Corporate Governance, including ESG Matters","Public Company Board","audit committee financial expert"] | ["Audit and Finance Committee","Compensation and Talent Development Committee","audit committee","finance and investment committee"] | 2026 |
| Wayne Burris | Chair; Independent Director | 71 | ["audit committee financial expert","Senior Executive Leadership","Former CFO/Financial Expertise","Healthcare Industry","Global Business","Mergers & Acquisitions","Corporate Governance, including ESG Matters","Operational Management","Compliance Quality & Regulatory","Public Company Board"] | ["Audit and Finance Committee","Compensation and Talent Development Committee","Audit & Finance (Chair)","Nominating","Governance & Sustainability"] | 2026 |
| W. BURRIS | ["Former CFO/Financial Expertise"] | [] | 2026 |
